Involuntary care was put in the spotlight last fall during the provincial election campaign when Premier David Eby announced plans to expand that type of care for people with addiction. The B.C.

In addition, B.C. recently updated its pneumococcal immunization program to include PCV20 (Prevnar-20) for children and adults. This vaccine provides broader and more effective protection against ...

Mucoactive agents did little to stave off pulmonary exacerbations of non-cystic fibrosis bronchiectasis, the CLEAR trial showed. In the two-by-two factorial trial testing hypertonic saline and ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today the company will present two oral ...

Horizon Health says recent changes by the Holt government won’t be enough to deal with the crisis of seniors on nursing-home waitlists taking up valuable space in the province’s hospitals.

Most of the births occurred at Argentinian and Chilean bases in Antarctica, at a time when those countries sought to strengthen their territorial claims.

Queen's University Belfast-led research reports on a multicenter trial finding no significant reduction in pulmonary exacerbations with hypertonic saline or carbocisteine over 52 weeks among adults ...

Wisconsin would be the 41 st state to legalize medical cannabis if a Republican-sponsored proposal introduced Monday becomes law. However, even the bill’s sponsor admit it’s a longshot despite strict ...

This important study identifies a putative iron and zinc transporter in the plasma membrane of the obligate intracellular pathogen, Toxoplasma gondii. Using an array of different approaches, the ...

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies geographically. Large trials are needed to assess safety and effectiveness.

United Therapeutics UTHR remains poised to expand Tyvaso’s label in the respiratory disease space. It recently unveiled results from the late-stage TETON-2 study, which showed clinical benefit in ...

Efficacy of Inhaled Molgramostim According to Severity of Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Session Title: Innovations in Assessment and Treatment of Fibrosing Lung Disease Session ID: ...